Cargando…
Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles
Depression is a major public health concern. Unfortunately, the present antidepressants often are insufficiently effective, whilst the discovery of more effective antidepressants has been extremely sluggish. The objective of this review was to combine the literature on depression with the pharmacolo...
Autor principal: | Kalkman, Hans O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045655/ https://www.ncbi.nlm.nih.gov/pubmed/36979785 http://dx.doi.org/10.3390/biomedicines11030806 |
Ejemplares similares
-
Modulation of microglial activation by antidepressants
por: Mariani, Nicole, et al.
Publicado: (2022) -
Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
por: Zhang, Kai, et al.
Publicado: (2020) -
Modulation of microglial function by the antidepressant drug venlafaxine
por: Dubovický, Michal, et al.
Publicado: (2014) -
Activation of σ1-Receptors by R-Ketamine May Enhance the Antidepressant Effect of S-Ketamine
por: Kalkman, Hans O.
Publicado: (2023) -
Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice
por: Szopa, Aleksandra, et al.
Publicado: (2015)